Table 2.
Sample‘n’ | Avg Age | % Female | % Hispanic Latino | % Wisconsin | % Long Island | Serum Collected after treatment? | ||
---|---|---|---|---|---|---|---|---|
Pilot Set | Control | n=7 | 46.4 | 42.9 | 42.9 | 0 | 100 | Not Applicable |
Pilot Set | Lyme disease | n=5 Acute n=3 Treated | 51.4 | 40.0 | 40.0 | 0 | 100 | Yes |
Confirmatory Set | Control | n=18 | 51.3 | 40.9 | 22.7 | 18.2 | 81.8 | Not Applicable |
Confirmatory Set | Lyme disease | n=18 Acute n=18 Treated | 53.1 | 40.0 | 20.0 | 20.0 | 80.0 | Yes |
Healthy Control and Lyme disease LD with matched Acute and Post-treatment Demographics of Bay Area Lyme Disease Biobank Serum Samples. Sample ID numbers are linked to demographic details including age, sex, ethnicity, and if the patient donated a post-treatment convalescent serum sample.